Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Il Minn

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
The Lancet. Oncology|August 1, 2019
Enhancing CAR T-cell therapy through cellular imaging and radiotherapyIl Minn, Steven P Rowe, Martin G Pomper
Fluids and Barriers of the CNS|July 12, 2016
In vitro characterization of pralidoxime transport and acetylcholinesterase reactivation across MDCK cells and stem cell-derived human brain microvascular endothelial cells (BC1-hBMECs)Erin Gallagher, Il Minn, Janice E Chambers, et al.
Bioorganic Chemistry|May 29, 2019
Design and synthesis of dye-conjugated hepsin inhibitorsKyul Kim, Hongmok Kwon, Doyoung Choi, et al.
Bioconjugate Chemistry|January 14, 2014
Heterobivalent agents targeting PSMA and integrin-αvβ3Hassan M Shallal, Il Minn, Sangeeta R Banerjee, et al.
Oral Oncology|November 27, 2010
p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinomaJong-Lyel Roh, Sung Koo Kang, Il Minn, et al.
Journal of Biophotonics|April 14, 2018
Prostate-specific membrane antigen-targeted photoacoustic imaging of prostate cancer in vivoHaichong K Zhang, Ying Chen, Jeeun Kang, et al.
Bioorganic Chemistry|October 4, 2020
Structure-activity relationship studies of prostate-specific membrane antigen (PSMA) inhibitors derived from α-amino acid with (S)- or (R)-configuration at P1' regionHongmok Kwon, Hyunwoong Lim, Hyunsoo Ha, et al.
Nuclear Medicine and Biology|May 27, 2018
Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitorsGanesan Vaidyanathan, Choong Mo Kang, Darryl McDougald, et al.
Pharmaceutics|February 26, 2022
A Unique Core-Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target EffectsBei Cheng, Hye-Hyun Ahn, Hwanhee Nam, et al.
European Journal of Medicinal Chemistry|April 30, 2016
Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligandsMilan Subedi, Il Minn, Jianbo Chen, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
The Lancet. Oncology|August 1, 2019
Enhancing CAR T-cell therapy through cellular imaging and radiotherapyIl Minn, Steven P Rowe, Martin G Pomper
Fluids and Barriers of the CNS|July 12, 2016
In vitro characterization of pralidoxime transport and acetylcholinesterase reactivation across MDCK cells and stem cell-derived human brain microvascular endothelial cells (BC1-hBMECs)Erin Gallagher, Il Minn, Janice E Chambers, et al.
Bioorganic Chemistry|May 29, 2019
Design and synthesis of dye-conjugated hepsin inhibitorsKyul Kim, Hongmok Kwon, Doyoung Choi, et al.
Bioconjugate Chemistry|January 14, 2014
Heterobivalent agents targeting PSMA and integrin-αvβ3Hassan M Shallal, Il Minn, Sangeeta R Banerjee, et al.
Oral Oncology|November 27, 2010
p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinomaJong-Lyel Roh, Sung Koo Kang, Il Minn, et al.
Journal of Biophotonics|April 14, 2018
Prostate-specific membrane antigen-targeted photoacoustic imaging of prostate cancer in vivoHaichong K Zhang, Ying Chen, Jeeun Kang, et al.
Bioorganic Chemistry|October 4, 2020
Structure-activity relationship studies of prostate-specific membrane antigen (PSMA) inhibitors derived from α-amino acid with (S)- or (R)-configuration at P1' regionHongmok Kwon, Hyunwoong Lim, Hyunsoo Ha, et al.
Nuclear Medicine and Biology|May 27, 2018
Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitorsGanesan Vaidyanathan, Choong Mo Kang, Darryl McDougald, et al.
Pharmaceutics|February 26, 2022
A Unique Core-Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target EffectsBei Cheng, Hye-Hyun Ahn, Hwanhee Nam, et al.
European Journal of Medicinal Chemistry|April 30, 2016
Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligandsMilan Subedi, Il Minn, Jianbo Chen, et al.
Pageof 7